Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

ADUS vs ACHC: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ADUS Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 7–3 Matrix Metrics)

ADUS Overall Winner 6-Pillar Tally: ADUS 4 – 2 ACHC Matrix Metrics: ADUS 7 – 3 ACHC

As of Nov 20, 2026, Addus HomeCare Corp. (ADUS) is the stronger overall head-to-head candidate over Acadia Healthcare Company, Inc. (ACHC) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ADUS carries a Unified Composite Score of 59.0/100 (HOLD) at $122.50 (16.1x Forward P/E, 10.4% operating margin), whereas ACHC carries 33.1/100 (SELL) at $34.60 (17.0x Forward P/E, 9.8% operating margin).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About ADUS vs ACHC
ADUS NASDAQ Head-to-Head Winner
Addus HomeCare Corp.
Services-Home Health Care Services
$122.50
+1.18% 1D
Market Cap $2.3B
TTM Revenue $1.50B
Forward P/E 16.1x
Beta / 30D Vol -0.07β · 21% Vol
Unified Composite Score
59.0 / 100 HOLD
Tech 57.0 Fund 52.0 Flow 50.0 Mom 46.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (1.9% over 20 days), RSI 52
RSI-14: 51.6 · SMA20: $123.87 · SMA50: $118.74
ACHC NASDAQ
Acadia Healthcare Company, Inc.
Services-Specialty Outpatient Facilities, Nec
$34.60
+0.38% 1D
Market Cap $3.2B
TTM Revenue $3.41B
Forward P/E 17.0x
Beta / 30D Vol 0.68β · 61% Vol
Unified Composite Score
33.1 / 100 SELL
Tech 15.0 Fund 36.0 Flow 59.0 Mom 36.4
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (8.1% over 20 days), RSI 52
RSI-14: 51.8 · SMA20: $34.42 · SMA50: $31.28

6-Pillar Scorecard Institutional Category Breakdown (ADUS 4 – 2 ACHC)

Columns: Metric · ADUS · ACHC
1. Valuation Multiples ADUS
Forward P/E 16.1x 17.0x
Trailing P/E 20.1x 16.9x
PEG Ratio 1.05x 1.37x
EV / Revenue 1.5x 1.6x
2. Growth & Scale ADUS
Revenue Growth (YoY) +7.0% +5.1%
Earnings Growth (YoY) +24.2% -5.1%
TTM Revenue (USD) $1.50B $3.41B
Market Cap $2.3B $3.2B
3. Profitability & Quality ADUS
Gross Margin 32.3% 41.0%
Operating Margin 10.4% 9.8%
Net Profit Margin 7.4% -33.1%
Return on Equity (ROE) 10.0% -40.5%
4. Balance Sheet & Cash Flow ADUS
Cash Generation (TTM) $173M EBITDA -$24M
Cash Flow Margin 11.5% EBITDA Mgn -0.7%
Net Cash / Leverage $64.64 Book/Sh · 10.0% ROE $2.34B Net Debt (1.24x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning ACHC
Options Structure Phase UNCLASSIFIED CONSOLIDATION
Current IV / %ile 21.9% (16th %ile) 49.8% (31st %ile)
Put/Call OI Skew N/A 0.39x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Markup NEUTRAL · Markup
6. R&D & Supply-Chain Moat ACHC
OpEx & R&D Intensity 21.9% of Rev ($329M) 31.2% of Rev ($1.06B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Medical Care Facilities Operator Medical Care Facilities Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: ADUS (7) vs ACHC (3)
Institutional Metric ADUS ACHC Criterion Row Edge
Market Capitalization
Scale
$2.3B $3.2B Larger Scale ACHC
Trailing P/E Ratio
Valuation
20.1x 16.9x Lower Multiple ACHC
Forward P/E Ratio
Valuation
16.1x 17.0x Lower Multiple ADUS
Revenue Growth (YoY)
Growth
+7.0% +5.1% Higher Growth ADUS
Operating Margin (TTM)
Profitability
10.4% 9.8% Higher Margin ADUS
Net Profit Margin
Profitability
7.4% -33.1% Higher Margin ADUS
Return on Equity (ROE)
Capital Efficiency
10.0% -40.5% Higher ROE ADUS
52-Week Range Position
Momentum
79% ($88–$132) 82% ($11–$40) Stronger Trend ACHC
Beta / 30D Volatility
Risk Regime
-0.07β · 21% Vol 0.68β · 61% Vol Lower Realized Risk ADUS
Unified Institutional Score
Composite Signal
59.0 / 100 (HOLD) 33.1 / 100 (SELL) Higher Composite ADUS
Trailing 12M Revenue (USD)
Operating Scale
$1.50B $3.41B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
32.3% 41.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.05x PEG · 1.5x EV/Rev 1.37x PEG · 1.6x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$173M EBITDA ($64.64 Book/Sh · 10.0% ROE) -$24M ($2.34B Net Debt (1.24x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon ACHC +8.67 pp
ADUS: -0.14% · ACHC: +8.53%
3M Horizon ACHC +19.08 pp
ADUS: +1.39% · ACHC: +20.47%
6M Horizon ACHC +17.05 pp
ADUS: +32.22% · ACHC: +49.27%
1Y Horizon ACHC +128.89 pp
ADUS: +12.39% · ACHC: +141.28%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ADUS vs ACHC. Trailing 12-month operating profitability (ADUS 10.4% vs ACHC 9.8%) and valuation multiples (ADUS 16.1x vs ACHC 17.0x Forward P/E) are benchmarked directly in Pillar 4 below.

ADUS ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.50B
Gross Margin32.3%
Op. Margin10.4%
ROE / Fwd P/E10.0% · 16.1x
ACHC ADR TTM Benchmark FX-Normalized USD
TTM Revenue$3.41B
Gross Margin41.0%
Op. Margin9.8%
ROE / Fwd P/E-40.5% · 17.0x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
ADUS UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 21.9%
IV Percentile 16th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ADUS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ACHC CONSOLIDATION
87d in phase · OBV NEUTRAL
Current IV 49.8%
IV Percentile 31st %ile
Put/Call OI Skew 0.39x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BEARISH
OBV Flow NEUTRAL
Exact ACHC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $38.10 · IV 47.7%

ACHC Simulated 5-Day Option Payoffs vs. Owning 100 Shares ($3,810)

Compare $3,810 in 100-share capital outlay against risk-defined 5-day vertical spreads, put-wall income, and 3-leg structures at 47.7% ATM IV.

PUT-WALL MONTHLY INCOME Liq C

Jan 15 '27 $35 / $30 Bull Put Spread

Sell 1x $35P · Buy 1x $30P · 59d

Net Entry $112 Credit
Max Credit / Yield +$112 (+28.9% RoM)
Max Risk / Buffer -11.1% Cushion ($388 Mgn)
5d Edge & Liquidity 71% PoP · Liq C
Simulate 5-Day Payoff →
5-DAY DOWNSIDE SPREAD Liq C

Dec 18 $40 / $35 Bear Put Spread

Buy 1x $40P · Sell 1x $35P · 31d

Net Entry $220 Debit
T+5d @ -5% Drop +$73 (+33%)
Max Risk / Buffer $220 Capped
5d Edge & Liquidity 0.9x R:R · Liq C
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
ADUS Moat Profile Cyclical / Execution-Driven Positioning
Medical Care Facilities Operator
Competes within the Medical Care Facilities value chain with $2.3B market capitalization and 10.4% operating margin.
OpEx & R&D Reinvestment 21.9% of Rev ($329M)
90D Engineering Disclosures 0 Published
ACHC Moat Profile Cyclical / Execution-Driven Positioning
Medical Care Facilities Operator
Competes within the Medical Care Facilities value chain with $3.2B market capitalization and 9.8% operating margin.
OpEx & R&D Reinvestment 31.2% of Rev ($1.06B)
90D Engineering Disclosures 0 Published

Investor FAQ ADUS vs ACHC Key Questions & Quantitative Answers

As of Nov 20, 2026, Addus HomeCare Corp. (ADUS) is the stronger overall head-to-head candidate over Acadia Healthcare Company, Inc. (ACHC) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ADUS carries a Unified Composite Score of 59.0/100 (HOLD) at $122.50 (16.1x Forward P/E, 10.4% operating margin), whereas ACHC carries 33.1/100 (SELL) at $34.60 (17.0x Forward P/E, 9.8% operating margin). Technically, ADUS sits in a Markup phase (RSI 51.6, UNCLASSIFIED options structure) and ACHC sits in a Markup phase (RSI 51.8, CONSOLIDATION options structure).

ADUS leads the Growth & Scale pillar: ADUS posts +7.0% YoY revenue growth and +24.2% YoY earnings growth on $1.50B TTM revenue (32.3% gross margin, 10.4% operating margin), compared with ACHC at +5.1% YoY revenue growth and -5.1% YoY earnings growth on $3.41B TTM revenue (41.0% gross margin, 9.8% operating margin). On trailing 12-month operating scale, ADUS generates $1.50B in USD-normalized revenue versus $3.41B for ACHC. In operating R&D and SG&A reinvestment, ADUS deploys 21.9% of Rev ($329M) (0 90-day corporate R&D disclosures) versus 31.2% of Rev ($1.06B) (0 disclosures) for ACHC.

ADUS screens cheaper on headline valuation multiples. ADUS trades at 16.1x Forward P/E, 20.1x Trailing P/E, 1.05x PEG, and 1.5x EV/Revenue (11.5% EBITDA margin), whereas ACHC trades at 17.0x Forward P/E, 16.9x Trailing P/E, 1.37x PEG, and 1.6x EV/Revenue (-0.7% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ADUS (10.0% ROE) versus ACHC (-40.5% ROE) capital efficiency.

In options market volatility and institutional positioning, ADUS carries 21.9% implied volatility (16th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.07β · 21% Vol realized risk). By comparison, ACHC carries 49.8% implied volatility (31st %ile, Balanced (25th–60th %ile)), a 0.39x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (0.68β · 61% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.